JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

Home・Elenco Azioni・Microbot Medical Inc

Microbot Medical Inc

Aperta

2.17 -0.91

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.16

Massimo

2.21

Metriche Chiave
By Trading Economics
Entrata	113K -3.5M
Dipendenti	43
EBITDA	-561K -4.1M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+240.91% upside

Dividendi
By Dow Jones
Utili prossimi	12 mag 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-15M 154M
Apertura precedente	3.08
Chiusura precedente	2.17

Punteggio Tecnico

By Trading Central

Fiducia

Neutral Evidence

2.52 / 2.57 Supporto e resistenza

Microbot Medical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

26 apr 2026, 21:14 UTC

Principali Notizie su Eventi

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26 apr 2026, 21:14 UTC

Principali Notizie su Eventi

Week Ahead for FX, Bonds: Major Central Bank -2-

24 apr 2026, 19:19 UTC

Acquisizioni, Fusioni, Takeovers

Intertek Group Rejects EQT's Revised Offer

26 apr 2026, 23:48 UTC

Discorsi di Mercato

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26 apr 2026, 23:44 UTC

Utili

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26 apr 2026, 23:44 UTC

Utili

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26 apr 2026, 23:36 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Gold Falls Amid Dollar's Strength -- Market Talk

26 apr 2026, 23:33 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26 apr 2026, 05:12 UTC

Utili

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26 apr 2026, 05:12 UTC

Utili

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26 apr 2026, 05:12 UTC

Utili

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26 apr 2026, 05:12 UTC

Utili

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24 apr 2026, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Scoring the Cook Era -- Barrons.com

24 apr 2026, 20:51 UTC

Acquisizioni, Fusioni, Takeovers

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 20:50 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Financial Services Roundup: Market Talk

24 apr 2026, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

24 apr 2026, 20:39 UTC

Acquisizioni, Fusioni, Takeovers

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 20:09 UTC

Utili

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 apr 2026, 19:48 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 apr 2026, 19:25 UTC

Acquisizioni, Fusioni, Takeovers

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 19:25 UTC

Acquisizioni, Fusioni, Takeovers

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 apr 2026, 19:22 UTC

Utili

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 apr 2026, 19:06 UTC

Utili

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 apr 2026, 19:05 UTC

Discorsi di Mercato

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 apr 2026, 18:30 UTC

Acquisizioni, Fusioni, Takeovers

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 apr 2026, 18:28 UTC

Acquisizioni, Fusioni, Takeovers

Intertek Rejects Revised EQT Offer

24 apr 2026, 18:12 UTC

Discorsi di Mercato

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 apr 2026, 18:06 UTC

Discorsi di Mercato

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 apr 2026, 17:42 UTC

Utili

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 apr 2026, 17:28 UTC

Utili

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Confronto tra pari

Modifica del prezzo

Microbot Medical Inc Previsione

Obiettivo di Prezzo

By TipRanks

240.91% in crescita

Previsioni per 12 mesi

Media 7.5 USD 240.91%

Alto 12 USD

Basso 5 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Microbot Medical Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 3 che hanno fornito valutazioni azionarie a Microbot Medical Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

2.52 / 2.57Supporto e resistenza

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.